139 related articles for article (PubMed ID: 22583460)
1. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
Wong CK; Lam CL; Rowen D; McGhee SM; Ma KP; Law WL; Poon JT; Chan P; Kwong DL; Tsang J
Value Health; 2012 May; 15(3):495-503. PubMed ID: 22583460
[TBL] [Abstract][Full Text] [Related]
2. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
Wong CK; Lam CL; Wan YF; Rowen D
Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
[TBL] [Abstract][Full Text] [Related]
3. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
Richardson SS; Berven S
Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
[TBL] [Abstract][Full Text] [Related]
4. Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.
Lee L; Kaneva P; Latimer E; Feldman LS
J Surg Res; 2014 Jan; 186(1):135-41. PubMed ID: 24021906
[TBL] [Abstract][Full Text] [Related]
5. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.
Teckle P; McTaggart-Cowan H; Van der Hoek K; Chia S; Melosky B; Gelmon K; Peacock S
Health Qual Life Outcomes; 2013 Dec; 11():203. PubMed ID: 24289488
[TBL] [Abstract][Full Text] [Related]
6. Mapping MOS Sleep Scale scores to SF-6D utility index.
Yang M; Dubois D; Kosinski M; Sun X; Gajria K
Curr Med Res Opin; 2007 Sep; 23(9):2269-82. PubMed ID: 17697450
[TBL] [Abstract][Full Text] [Related]
7. Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.
Yang Q; Huang D; Jiang L; Tang Y; Zeng D
Front Endocrinol (Lausanne); 2023; 14():1160882. PubMed ID: 37664851
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China.
Yang Q; Jiang LL; Li YF; Huang D
Health Qual Life Outcomes; 2023 Nov; 21(1):122. PubMed ID: 37964348
[TBL] [Abstract][Full Text] [Related]
9. Valuing postoperative recovery: validation of the SF-6D health-state utility.
Lee L; Elfassy N; Li C; Latimer E; Liberman AS; Charlebois P; Stein B; Carli F; Fried GM; Feldman LS
J Surg Res; 2013 Sep; 184(1):108-14. PubMed ID: 23522456
[TBL] [Abstract][Full Text] [Related]
10. Predicting health-utility scores from the Cervical Spine Outcomes Questionnaire in a multicenter nationwide study of anterior cervical spine surgery.
Skolasky RL; Carreon LY; Anderson PA; Albert TJ; Riley LH
Spine (Phila Pa 1976); 2011 Dec; 36(25):2211-6. PubMed ID: 21343870
[TBL] [Abstract][Full Text] [Related]
11. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.
Yousefi M; Nahvijou A; Sari AA; Ameri H
Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752
[TBL] [Abstract][Full Text] [Related]
12. Improving the mapping of condition-specific health-related quality of life onto SF-6D score.
Yang Y; Wong MY; Lam CL; Wong CK
Qual Life Res; 2014 Oct; 23(8):2343-53. PubMed ID: 24682669
[TBL] [Abstract][Full Text] [Related]
13. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain.
Søgaard R; Christensen FB; Videbaek TS; Bünger C; Christiansen T
Value Health; 2009 Jun; 12(4):606-12. PubMed ID: 19900258
[TBL] [Abstract][Full Text] [Related]
14. Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.
Skaltsa K; Longworth L; Ivanescu C; Phung D; Holmstrom S
Value Health; 2014 Mar; 17(2):238-44. PubMed ID: 24636382
[TBL] [Abstract][Full Text] [Related]
15. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
[TBL] [Abstract][Full Text] [Related]
16. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
[TBL] [Abstract][Full Text] [Related]
18. Oral mucositis and quality of life of Hong Kong Chinese patients with cancer therapy.
Cheng KK
Eur J Oncol Nurs; 2007 Feb; 11(1):36-42. PubMed ID: 17258505
[TBL] [Abstract][Full Text] [Related]
19. The influence of ethnicity on health-related quality of life in diabetes mellitus: a population-based, multiethnic study.
Wee HL; Li SC; Cheung YB; Fong KY; Thumboo J
J Diabetes Complications; 2006; 20(3):170-8. PubMed ID: 16632237
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
